Apolipoprotein B (APOB)-containing very LDL (VLDL) production, secretion, and clearance by hepatocytes is a central determinant of hepatic and circulating lipid levels. Impairment of any of the aforementioned processes is associated with the development of multiple diseases. Despite the discovery of genes and processes that govern hepatic VLDL metabolism, our understanding of the different mechanistic steps involved is far from complete. An impediment to these studies is the lack of tractable hepatocyte-based systems to interrogate and follow APOB in cells, which the current study addresses.


You can read the full story here!

Share this message

Latest news Medical Biochemistry Amsterdam

By duda-wsm June 17, 2025
Project MERCURY is taking off! Prof Noam Zelcer has been awarded an NWO open competition grant to study hepatic APOB metabolism and VLDL production. To do so, innovative proteomic and genetic approaches coupled to in vivo studies will be used to understand how APOB/VLDL is lipidated, trafficked, and secreted in hepatocytes.
By duda-wsm May 28, 2025
At the annual Dutch Atherosclerosis Society (DAS) meeting, Lobke received the award for Best Flash Talk for her presentation on the role of LXR in macrophage immune activation, while Ricky was awarded Best Poster Presentation for his work on the role of IRF1 in macrophage function. Congratulations to both!
Show More